Literature DB >> 25207078

Protective effects of erythropoietin and N-acetylcysteine on methotrexate-induced lung injury in rats.

Hasan Kahraman1, Ergül Kurutaş2, Mahmut Tokur3, Selim Bozkurt4, Harun Cıralık5, Betül Kabakcı2, Nurhan Köksal1, Vedat Balkan6.   

Abstract

OBJECTIVE: Methotrexate (MTX) is known to have deleterious side effects on lung tissue. We aimed to investigate the effects of erythropoietin (EPO) and N-acetyl-cysteine (NAC) on MTX-induced lung injury in rats. STUDY
DESIGN: Animal experiment.
MATERIAL AND METHODS: Twenty-six female Sprague-Dawley rats were divided into 4 groups. Sham group, 0.3 mL saline; MTX group, 5 mg/kg MTX; EPO group, 5mg/kg MTX and 2000 IU/kg EPO; NAC group, 5 mg/kg MTX and 200 mg/kg NAC were administered once daily for 4 consecutive days. Malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT) and inflammation and congestion scores in lung tissues were evaluated.
RESULTS: In MTX group MDA were significantly higher, CAT and SOD were significantly lower than in sham, EPO and NAC groups (p<0.005). In EPO group MDA, CAT, and SOD were higher, but not significant than those in group NAC (p>0.005). In group MTX both scores were significantly higher than in sham (p<0.005). The congestion score of group MTX was significantly higher than those of group EPO and NAC (p<0.005).
CONCLUSION: EPO and NAC have significant preventive effects on MTX-induced lung injury in rats. Decreased antioxidant capacity and increased MDA level may cause the oxidative damage in MTX group. Also, higher antioxidant capacity and lower MDA level may be a response to oxidative stress in EPO and NAC groups.

Entities:  

Keywords:  Methotrexate; N-acetyl-cysteine; erythropoietin; lung; oxidative damage

Year:  2013        PMID: 25207078      PMCID: PMC4116011          DOI: 10.5152/balkanmedj.2012.078

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  37 in total

Review 1.  Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.

Authors:  M Brines; A Cerami
Journal:  Kidney Int       Date:  2006-05-31       Impact factor: 10.612

2.  N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation.

Authors:  Renata Campos; Maria Heloísa Massola Shimizu; Rildo Aparecido Volpini; Ana Carolina de Bragança; Lucia Andrade; Fernanda Degobbi Tenório Quirino Dos Santos Lopes; Clarice Olivo; Daniele Canale; Antonio Carlos Seguro
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-20       Impact factor: 5.464

3.  Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro.

Authors:  Masayuki Ohbayashi; Masanori Suzuki; Yoshiki Yashiro; Sayaka Fukuwaka; Masako Yasuda; Noriko Kohyama; Yasuna Kobayashi; Toshinori Yamamoto
Journal:  J Toxicol Sci       Date:  2010-10       Impact factor: 2.196

4.  Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats.

Authors:  Haiwei Wu; Binhui Ren; Jiaquan Zhu; Guohua Dong; Biao Xu; Changtian Wang; Xiaogang Zheng; Hua Jing
Journal:  Eur J Cardiothorac Surg       Date:  2006-05-03       Impact factor: 4.191

5.  Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice.

Authors:  Claudio Contaldo; Christoph Meier; Ahmed Elsherbiny; Yves Harder; Otmar Trentz; Michael D Menger; Guido A Wanner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-02       Impact factor: 4.733

Review 6.  Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease.

Authors:  I Rahman; W MacNee
Journal:  Am J Physiol       Date:  1999-12

7.  Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats.

Authors:  Abdullah Kumral; Sevil Gonenc; Osman Acikgoz; Atac Sonmez; Kursad Genc; Osman Yilmaz; Necati Gokmen; Nuray Duman; Hasan Ozkan
Journal:  Biol Neonate       Date:  2004-08-27

8.  Oxidative stress and protective effect of erythropoietin on methotrexate-induced esophageal damage.

Authors:  Mesut Garipardic; Vedat Bakan; Mehmet Davutoğlu; Hamide Sayar; Ergül Belge Kurutaş
Journal:  J Pediatr Hematol Oncol       Date:  2010-03       Impact factor: 1.289

9.  In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction.

Authors:  J Fandrey; H F Bunn
Journal:  Blood       Date:  1993-02-01       Impact factor: 22.113

10.  Methotrexate induces interleukin-8 production by human bronchial and alveolar epithelial cells.

Authors:  Yasuhiro Yamauchi; Hitoshi Okazaki; Masashi Desaki; Tadashi Kohyama; Shin Kawasaki; Kazuhiko Yamamoto; Hajime Takizawa
Journal:  Clin Sci (Lond)       Date:  2004-06       Impact factor: 6.124

View more
  3 in total

1.  Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats.

Authors:  Sami Akbulut; Hulya Elbe; Cengiz Eris; Zumrut Dogan; Gulten Toprak; Emrah Otan; Erman Erdemli; Yusuf Turkoz
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

2.  Alleviation of chemotherapy-induced acute lung injury via NLRP3/ ASC/ Caspase-1 signaling pathway.

Authors:  Iman O Sherif; Nora H Al-Shaalan
Journal:  Toxicol Res (Camb)       Date:  2022-04-27       Impact factor: 2.680

3.  Effect of lutein on methotrexate-induced oxidative lung damage in rats: a biochemical and histopathological assessment.

Authors:  Renad Mammadov; Bahadir Suleyman; Selcuk Akturan; Ferda Keskin Cimen; Nezahat Kurt; Zeynep Suleyman; İsmail Malkoc
Journal:  Korean J Intern Med       Date:  2019-09-10       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.